Falcon Point Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,679	Closed	-$849K	–	126
2018 Q1	$849K	Sell	9,679 -2,055	-18%	-$188K	0.17%	76
2017 Q4	$996K	Sell	11,734 -9,336	-44%	-$782K	0.17%	74
2017 Q3	$1.76M	Sell	21,070 -1,032	-5%	-$82.7K	0.26%	61
2017 Q2	$1.71M	Sell	22,102 -4,568	-17%	-$324K	0.23%	65
2017 Q1	$1.85M	Buy	26,670 +819	+3%	+$55K	0.25%	61
2016 Q4	$1.53M	Buy	25,851 +770	+3%	+$47.5K	0.2%	63
2016 Q3	$1.41M	Buy	25,081 +2,229	+10%	+$138K	0.22%	63
2016 Q2	$1.24M	Buy	22,852 +2,552	+13%	+$140K	0.21%	70
2016 Q1	$1.05M	Buy	20,300 +2,268	+13%	+$118K	0.18%	75
2015 Q4	$1.27M	Buy	18,032 +1,217	+7%	+$83K	0.27%	62
2015 Q3	$1.05M	Sell	16,815 -3,750	-18%	-$296K	0.37%	69
2015 Q2	$1.73M	Sell	20,565 -72	-0.3%	-$5.6K	0.58%	53
2015 Q1	$1.55M	Buy	20,637 +162	+0.8%	+$11.3K	1.21%	31
2014 Q4	$1.27M	Buy	20,475 +3,192	+18%	+$182K	1.17%	33
2014 Q3	$899K	Buy	+17,283	New	+$881K	0.76%	52